Satipharm begins clinical trial of CBD capsules for treating menopause
Category: #health  By Saipriya Iyer  Date: 2020-02-21
  • sharesocial_share_icon
  • Twitter
  • Facebook
  • LinkedIn

Satipharm begins clinical trial of CBD capsules for treating menopause

Cannabis was prior considered to possess various medicinal benefits for treating diseases. However, after years of restriction, the scientific community is finally exploring the medical avenues of CBD by conducting advanced clinical trials and creating new formulations.

Recently, Satipharm Ltd., a wellness and health firm, took a pioneering step towards this direction by initiating a clinical research on CBD capsules for offering patients the needed relief from menopause symptoms.

After the fruitful conclusion of Phase II clinical study indicating that Satipharm CBD capsules minimized seizures in kids with an average 73% of treatment-resistant epilepsy, the company is reportedly shifting its focus towards menopause and perimenopause.

Reports cite that using these advanced CBD capsules along with Gelpell® delivery technology, which is developed under Good Manufacturing Practice ("GMP"), would allow Satipharm to validate its patented CBD formulation as it offers substantial relief from physiological-based symptoms.

Speaking on the move, Jonathan Hartshorn, CEO, Satipharm, said that delivering clinical proof to its users, upon which they can rely on to take their healthcare decisions, has been a key objective for Satipharm.

After the success of its Phase II clinical study in epilepsy, the company has been constantly exploring new avenues of research to progress its understanding of CBD. It is observing numerous evidence that bolsters the benefits of CBD for women looking for relief from menopausal and perimenopausal symptoms.

However, the Food Standards Agency (FSA) has a contradicting opinion over the use of CBD by expecting women. The regulator has warned breastfeeding mothers and pregnant women to restrict their CBD medications to no more than 70mg a day.

As for CBD businesses, the regulator warned that their products could hit the bins if they failed to clarify the contents and safety of their items by the end of March 2021. Meanwhile, manufacturers are requested to register themselves with the FSA for “novel food authorization”. This grade would help the public to gain perspective about the safety profile of CBD products.

Source Credit: https://finance.yahoo.com/news/satipharm-initiates-clinical-research-cbd-080000122.html



About Author

Saipriya Iyer

Email: [email protected]   linkdin twitter

Saipriya Iyer

Saipriya Iyer develops content for Market Size Forecasters, Algosonline, and myriad other platforms. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her bel...

More News By Saipriya Iyer

 Tabletop Tape Dispensers  market valuation to surge at healthy CAGR through 2026

Tabletop Tape Dispensers market valuation to surge at healthy CAGR through 2026

By Saipriya Iyer

A comprehensive research study on Tabletop Tape Dispensers market added by Market Study Report provides insights into the market size and growth trends of this industry over the forecast timeline. The study evaluates key aspects of Tabletop Tape D...

APAC, Europe, America region to generate massive revenues for General Well-Being Dietary Supplements market by 2026

APAC, Europe, America region to generate massive revenues for General Well-Being Dietary Supplements market by 2026

By Saipriya Iyer

MarketStudyReport.com presents latest report on global General Well-Being Dietary Supplements Market, which evaluates the growth trends of the industry through historical study and estimates future prospects based on comprehensive research. The re...

Eugenia Jambolana Extract Market to Increase Exponentially During 2027

Eugenia Jambolana Extract Market to Increase Exponentially During 2027

By Saipriya Iyer

The report Eugenia Jambolana Extract market provides high-quality information regarding the major market trends, product types and their application scope, competitive landscape, and impact of COVID-19 outbreak.

.

Request a...